COVID-19 pandemic has led to a surge in demand for ayurvedic medicine.
Individuals and communities are prioritizing staying safe and secure in the face of this global pandemic. Not only has this resulted in an increase in demand for cleaning items such as sanitizers and disinfectants, which protect against COVID-19 transmission from outside sources, but it has also resulted in an increase in demand for immune-boosting supplements and medicine, which has led to a spike in the demand for ayurvedic medicine. The most important effect of COVID-19 on Ayurveda has been on people’s attitudes toward Ayurveda. Ayurveda was known as a pharmaceutical approach, and it was used to treat particular illnesses. Ayurveda, on the other hand, is all about prevention and holistic wellbeing. It advises a well-balanced lifestyle in order to avoid rather than cure problems. People have become more mindful of staying healthy and avoiding disease as a result of COVID-19. And Ayurveda is well adapted to such a holistic approach to wellness.
The benefit of Ayurveda is that the substance or ingredients are not toxic, which means there is a higher chance of success. The market opportunity is also important, considering that Ayurveda can resolve both mild and chronic health problems. Together, they represent a powerful business opportunity. Together, they represent a powerful business opportunity. Prior to Covid, the ayurvedic market expanded at a rate of 15-20% per year. Many businesses, large and small, have experienced growth of 50-90 percent in the last year. The industry would benefit from the adoption of Ayurveda as a holistic, natural healthcare system.
The AYUSH ministry of trade and industry is preparing to meet the increased demand for Ayurvedic medicine and disease-prevention solutions for Covid-19, amidst growing global interest and demand for ayurvedic medicine and disease-prevention solutions. “The various initiatives taken by the Ministry of AYUSH have been found significantly useful not only in India but in different parts of the world which relates to unprecedented demand for Ayurveda Medicine. There is emerging evidence of large-scale adoption of AYUSH-based prophylactic solutions by the people,” the AYUSH ministry said in a statement.
A global perspective is needed to fully establish Ayurveda. And, in order to serve global markets, we’ll have to adhere to international clinical validation and trial requirements. A clinical validation phase in another country will cost about USD 500 million or more on average. There are many levels to this method, each with its own set of standards. Given the high investment needed, AYUSH will need to develop the necessary standards and likely help organizations to carry them out in the Indian ecosystem.